medroxyprogesterone acetate has been researched along with Ventricular Dysfunction, Left in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arias-Loza, PA; Bayer, B; Dienesch, C; Ertl, G; Frantz, S; Hu, K; Pelzer, T; Wu, R | 1 |
1 other study(ies) available for medroxyprogesterone acetate and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Medroxyprogesterone acetate aggravates oxidative stress and left ventricular dysfunction in rats with chronic myocardial infarction.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiomegaly; Chronic Disease; Electrocardiography; Estradiol; Female; Heart Rate; Histocytochemistry; Medroxyprogesterone Acetate; Myocardial Infarction; NADPH Oxidases; Ovariectomy; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |